Insider Deck research · News

INSM stock news · Insmed Incorporated

Latest Insmed Incorporated (INSM) stock news, headlines, and research context on Insider Deck. Sector: Healthcare. Industry: Biotechnology. Market cap $21.5B.

News desk

Insmed Incorporated wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

8 on the wireUpdated within the hour

Zacks·Wed, Aug 5, 9:10 PM

Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates

Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of +22.22% and +6.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Insider Deck desk note

Last$99.02
Day+0.27%
SymbolINSM

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on Zacks

Frequently asked questions

What is the latest news on INSM?

The INSM news desk aggregates recent headlines with research context for Insmed Incorporated (Healthcare).

Where can I research INSM on Insider Deck?

Insmed Incorporated (INSM) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.